Price:- $92 for 30 capsules Packaging Size 30 Capsules Packaging Type Bottle Brand Nitib 140mg Capsule Manufacturer Hetero Healthcare Limited Strength 140 mg Nitib, Ibrutinib (140mg) USA FAST DELIVERY Nitib, Ibrutinib (140mg:WE EXPORT,We Export in, KioBedok,Bishan,Bukit Batok,Bukit Merah, Bukit Panjang,Choa Chu Kang, Clementi,Geylang,Hougang, Jurong East, Jurong West, Kallang, Marine Parade, Queenstown ,Sengkang, Simei ,Tampines,. Toa Payoh,Woodlands, Yishun Nitib, Ibrutinib (140mg) UK FAST DELIVERY Nitib, Ibrutinib (140mg:WE EXPORT,London, Birmingham, Manchester, Liverpool, Leeds, Sheffield, Bradford, Bristol, Coventry, Nottingham, Newcastle upon Tyne, Oxford, Cambridge, York, Wakefield, Sunderland, Stoke-on-Trent, Southampton, Sheffield, Salford, Salisbury, Ripon, Truro, Wells, Westminster, Winchester, Wolverhampton, Worcester, Edinburgh, Glasgow, Aberdeen, Dundee, Inverness, Perth, Stirling, Dunfermline, Cardiff, Swansea, Newport, Bangor, St Asaph, St Davids, Wrexham, Belfast, Armagh, Londonderry, Lisburn, Newry, Bangor, Douglas, Hamilton, City of Gibraltar, Stanley, Jamestown. Nitib, Ibrutinib (140mg)UAE FAST DELIVERY Nitib, Ibrutinib (140mg:WE EXPORT IN,Abu Dhabi, Al Ain, Al Dhannah, Madinat Zayed, Liwa Oasis, Ghayathi, Ar Ruways, Dubai, Jebel Ali, Hatta, Al Aweer, Al Marmoom, Sharjah, Khor Fakkan, Dibba Al-Hisn, Kalba, Al Dhaid, Mleiha, Al Saja'a, Ajman, Masfout, Umm Al Quwain, Al Sufouh, Ras Al Khaimah, Al Jazirah Al Hamra, Ar-Rams , Fujairah, Dibba Al-Fujairah, Masafi. Nitib, Ibrutinib (140mg) SINGHAPORE FAST DELIVERY Nitib, Ibrutinib (140mg:WE EXPORT IN, Central Region, North Region, North-East Region, West Region, East Region. Product introductionNitib 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy. Nitib 140mg Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects. Ibrutinib 140 mg capsules, marketed under the brand name Imbruvica, are used in the United States for treating various B-cell malignancies and related conditions. 🩺 Medical Uses Imbruvica is FDA-approved for the treatment of: Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) Mantle cell lymphoma (MCL) Waldenström’s macroglobulinemia (WM) Marginal zone lymphoma (MZL) Chronic graft-versus-host disease (cGVHD) It functions as a Bruton's tyrosine kinase (BTK) inhibitor, disrupting B-cell receptor signaling to impede cancer cell proliferation . 💊 Dosage Form & Strength Available as 140 mg oral capsules Also offered in 70 mg and 420 mg tablet formulations 💰 Pricing & Availability Imbruvica 140 mg capsules are available in the U.S. through pharmacies Ibrutinib capsules 140 mg Imbruvica 140 mg Ibrutinib anticancer drug Ibrutinib BTK inhibitor Imbruvica for leukemia Ibrutinib USA pharmacy Ibrutinib prescription drug Ibrutinib FDA approved Ibrutinib oral chemotherapy -Ibrutinib for CLL Ibrutinib for SLL Ibrutinib for MCL Ibrutinib for WM Ibrutinib for marginal zone lymphoma Ibrutinib for cGVHD B-cell cancer treatment USA Chronic lymphocytic leukemia therapy Blood cancer oral treatment Ibrutinib generic USA Buy Imbruvica online Ibrutinib price in USA Ibrutinib patient assistance Ibrutinib insurance coverage Ibrutinib manufacturer AbbVie Ibrutinib wholesale supplier Ibrutinib oncology distributor Ibrutinib bulk exporter Ibrutinib 140 mg dosage Ibrutinib oral capsules Imbruvica capsule 140mg Daily dose of Ibrutinib Ibrutinib with or without food Ibrutinib treatment plan Ibrutinib side effects Ibrutinib black box warning Ibrutinib bleeding risk Ibrutinib atrial fibrillation Ibrutinib drug interactions Ibrutinib monitoring requirements Ibrutinib FDA label Ibrutinib clinical trials USA Imbruvica prescribing information Ibrutinib REMS program NCCN guidelines Ibrutinib Ibrutinib US package insert Ibrutinib Bruton’s tyrosine kinase inhibitor Ibrutinib pharmacokinetics Ibrutinib mechanism of action BTK inhibitor therapy Ibrutinib resistance mutation Ibrutinib dosing regimen Irreversible BTK inhibition Ibrutinib bioavailability Ibrutinib CYP3A interaction Ibrutinib online USA Buy Ibrutinib capsules USA Ibrutinib 140 mg price USA Ibrutinib prescription refill Imbruvica cost with insurance Order Ibrutinib from licensed pharmacy Discount Ibrutinib capsules Ibrutinib 140 mg capsule manufacturer FDA approved BTK inhibitors Targeted therapy for B-cell lymphoma Oral targeted anticancer drugs Hematologic malignancy treatment Ibrutinib

Product introduction Tasigna 200mg Capsule is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects. Tasigna 200mg Capsule should be taken on an empty stomach, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. Headache, nausea, abdominal pain, and rash are very common side effects of this medicine. If you experience severe diarrhea, consult with your doctor or drink plenty of fluids while on treatment. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver and blood uric acid levels and blood sugar or fat level in the body. Before taking it, tell your doctor if have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy. How to use Tasigna Capsule Take this medicine in the dose and duration as advised by your doctor. Tasigna 200mg Capsule is to be taken empty stomach. How Tasigna Capsule works Tasigna 200mg Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells. Safety advice 🔹 Primary Use Tasigna is used to treat: ✅ Chronic Myeloid Leukemia (CML) Specifically, Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia. It is used in patients: Who are newly diagnosed with chronic phase CML, or Whose disease has resisted or not responded to previous treatments like imatinib (Gleevec). 🧬 How It Works: Tasigna is a tyrosine kinase inhibitor. It blocks the activity of the BCR-ABL protein, which is produced by the Philadelphia chromosome and causes cancer cells to grow. By blocking this protein, Tasigna helps stop the growth of cancer cells. 📋 Common Dosage Typically: 200 mg taken twice daily, on an empty stomach. Must be taken at least 2 hours after eating and 1 hour before the next meal. 📄 Tasigna 200 mg Capsule – Specification Sheet 🔹 Brand Name: Tasigna 🔹 Generic Name: Nilotinib hydrochloride monohydrate 🔹 Strength: 200 mg per capsule 🔹 Dosage Form: Hard gelatin capsule 🔹 Route of Administration: Oral (by mouth) 🧪 Pharmacological Class: Tyrosine Kinase Inhibitor (TKI) Targets BCR-ABL protein (abnormal tyrosine kinase from the Philadelphia chromosome) 🧪 Pharmacological Class: Tyrosine Kinase Inhibitor (TKI) Targets BCR-ABL protein (abnormal tyrosine kinase from the Philadelphia chromosome) ✅ Indications (Diseases Treated): Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML): Chronic Phase (newly diagnosed) Chronic or Accelerated Phase (resistant or intolerant to prior therapy, including imatinib) Typical adult dose: 200 mg twice daily Must be taken on an empty stomach At least 2 hours after a meal Do not eat for 1 hour after taking it Typical adult dose: 200 mg twice daily Must be taken on an empty stomach At least 2 hours after a meal Do not eat for 1 hour after taking it Typical adult dose: 200 mg twice daily Must be taken on an empty stomach At least 2 hours after a meal Do not eat for 1 hour after taking it Typical adult dose: 200 mg twice daily Must be taken on an empty stomach At least 2 hours after a meal Do not eat for 1 hour after taking it vTypical adult dose: 200 mg twice daily Must be taken on an empty stomach At least 2 hours after a meal Do not eat for 1 hour after taking it Typical adult dose: 200 mg twice daily Must be taken on an empty stomach At least 2 hours after a meal Do not eat for 1 hour after taking it 🎯 Main Disease Treated: ✅ Chronic Myeloid Leukemia (CML) A type of blood cancer that affects the white blood cells and the bone marrow. WE EXPORT TO USA WE EXPORT TO UK WE EXPORT TO AUSTRALIA WE EXPORT TO UAE WE EXPORT TO SINGAPORE WE EXPORT TO ITALY WE EXPORT TO CANADA WE ARE A DROPSHIPPER